Friday 6-6-2014 Gilead Sciences (GILD) $GILD opened at

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
Friday 6-6-2014 Gilead Sciences (GILD) $GILD opened at 83.24 hitting the high price of 83.24 and a day low of 81.72 with a total volume of 9,105,200. GILD had a previous close of 82.80 and has been seeing an average volume of 9,896,689.

Overall Average: 40% Buy

Recent stock forum discussions about GILD http://investorshangout.com/search?q=GILD&...mp;yt0=Go!

The Repercussions of Medicare's New Hepatitis C Push
Michael Douglass and David Williamson, The Motley Fool - Motley Fool - Sun Jun 08, 12:31PM CDT
This week, the Centers for Medicare & Medicaid Services, or CMS, announced a big shift in health policy. CMS intends to cover screening for hepatitis C for members who fall into either of two buckets: those who are considered to be at high risk... (full story)

Final Glance: Biotechnology companies
AP - Fri Jun 06, 5:13PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading: (full story)

Curis Re-Initiates Dosing for CUDC-427 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 06, 4:10PM CDT
Curis, Inc. (CRIS) announced that it has re-initiated dosing in the single-agent clinical trial on pipeline candidate, CUDC-427. (full story)

Alkermes' Pipeline Holds Promise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 06, 3:30PM CDT
Alkermes (ALKS) announced the commencement of a 15-month phase II trial on ALKS 3831. (full story)

Jim Cramer: No Joy in Shortville
at The Street - Fri Jun 06, 12:42PM CDT
Shorts take much more homework than longs. (full story)

Midday Glance: Biotechnology companies
AP - Fri Jun 06, 12:22PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 1 p.m.: (full story)

Affymetrix, BioDiscovery Launch Cancer Research Software - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 06, 12:10PM CDT
Nexus Copy Number is an advanced discovery tool for interrogating large data sets, specifically tailored for analyzing data generated by Affymetrix Inc.'s (AFFX) genetic analysis platforms. (full story)

Early Glance: Biotechnology companies
AP - Fri Jun 06, 10:46AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 10 a.m.: (full story)

Pipeline Progress at GlaxoSmithKline - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 06, 10:26AM CDT
GlaxoSmithKline plc (GSK) recently announced that it has initiated a phase III study, LATITUDE-TIMI 60 on cardiovascular candidate losmapimod. (full story)

Celldex Therapeutics (CLDX) Soars: Stock Adds 12.6% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jun 06, 8:39AM CDT
Celldex Therapeutics, Inc. (CLDX) was a big mover last session, as its shares rose nearly 13% on the day. (full story)

Clovis Oncology (CLVS) Jumps: Stock Rises 6.2% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jun 06, 7:51AM CDT
Clovis Oncology, Inc. (CLVS) was a big mover last session, as its shares rose over 6% on the day. (full story)

MannKind Hits 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jun 06, 7:00AM CDT
Shares of MannKind (MNKD) hit a 52-week high of $11.11 during the trading session on Jun 5 (full story)

'Mad Money' Lightning Round: I'm Flying With American
at The Street - Fri Jun 06, 5:00AM CDT
Cramer is a believer in Charles Schwab and likes Gilead Sciences and Celgene. (full story)

Vertex Pharmaceuticals Inc.'s Date With Destiny
Brian Orelli, The Motley Fool - Motley Fool - Thu Jun 05, 7:29PM CDT
Vertex Pharmaceuticals said to expect data from two clinical trials testing its cystic fibrosis drugs midyear. It's June. Doesn't get much more midyear than that. The two trials, dubbed Traffic and Transport, are testing VX-809, at two different... (full story)

Jim Cramer's 'Mad Money' Recap: Follow Your Own Investment Path
at The Street - Thu Jun 05, 7:08PM CDT
Investors need to be their own gurus and decide for themselves when it's time to buy and sell. (full story)

Vanda Up on EU News - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 05, 6:01PM CDT
Vanda Pharmaceuticals Inc. (VNDA) announced that the European Medicines Agency (EMA) has accepted its Marketing Authorization Application (MAA) for Hetlioz. (full story)

Roche's Ventana Collaborates with AstraZeneca's MedImmune - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 05, 5:57PM CDT
Roche's (RHHBY) Ventana Medical Systems, Inc. has entered into a collaboration agreement with MedImmune, the global biologics research and development arm of AstraZeneca (AZN). (full story)

Positive Phase IIb Data from Jazz Pharma - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 05, 5:56PM CDT
Jazz Pharmaceuticals' (JAZZ) JZP-110 met all primary and secondary endpoints in a phase IIb study for the treatment of excessive daytime sleepiness (EDS) in adults suffering from narcolepsy. (full story)

Halozyme Study Clinical Hold Lifted by FDA - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jun 05, 5:26PM CDT
Halozyme Therapeutics, Inc. (HALO) announced that the FDA has removed the clinical hold from PEGPH20 phase II study (Study 202) for stage IV metastatic pancreatic cancer. (full story)

Gilead Sciences Inc. (GILD) Stock Research Links

GILD Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Strategic Hire: Whisenhunt Joins FlexScreen & RiteScreen

Updated Category News Views 1

Shaking Up the Window Screens Biz If you've been grinding in the window and door game, you know it's not an industry with a lot of buzz, but here comes a shot of caffeine. FlexScreen and RiteScreen just snagged David Whisenhunt to rev up their sales machine. Who's David Whisenhunt? Well, he's no rookie. With over two decades deep in the fenestration field, Whisenhunt...

Continue Reading
AllyGPO Shines as Top Innovator in Health Tech

Updated Category News Views 3

Innovative Excellence in Healthcare Tech It's not every day you see a specialty group purchasing organization like AllyGPO snagging a spot on Fast Company's esteemed list of Best Workplaces for Innovators. Making it into the top half at number 40 in 2026, it’s a testament to a company really leaning into employee-driven innovation. And, buddy, this ain't just corporate...

Continue Reading
Hanover Unveils Skinny Veg® for GLP-1 Dieters

Updated Category News Views 2

Seems like Hanover Foods is turning heads with their move into the ever-demanding health-conscious market. This family's stepping into the limelight with their new Skinny Veg® line, clearly targeting folks riding the GLP-1 wave. You see, it's not every day that a company that's been around the block since 1924 shakes things up like this. Simplicity is the Name of the...

Continue Reading
Webinar Highlights Workforce Skills and AI Tools

Updated Category News Views 2

The Shift Towards Skills-Based Talent Development The labor market's in a whirl, folks. Employers are scrambling to adapt to rapid changes, chasing after 'skills intelligence' like it's going out of style. On September 24, University of Phoenix, with its band of partners including Jobs for the Future and Skillmore™, will dig into this very topic. This upcoming webinar...

Continue Reading
Life Flower Celebrates 16 Years with Dog Adoption Event

Updated Category News Views 3

A Celebration with Heart Ah, the classic mix of business and community goodwill—that's what Life Flower Dispensary is all about this year. You know, not every business that hits the 16-year mark decides to make it about something bigger than just slashing prices or hyping themselves up. But Life Flower? They're using their anniversary to throw a shindig that's more than...

Continue Reading
Mandeville Pests: Health Dangers Lurking at Home

Updated Category News Views 1

Pest Trouble Brewing in Mandeville: A Health Alert There’s a storm brewing in Mandeville, Louisiana, and it's not the kind you can see rolling in on the horizon. We're talking about those sneaky pests going unnoticed in our homes. Folks, these pests aren't just a nuisance; they're ticking time bombs for public health. Take it from J&J Exterminating, who know a thing or...

Continue Reading
VitalCore Pioneers Jail Behavioral Health Expansion

Updated Category News Views 2

The Big Move in Correctional Healthcare VitalCore Health Strategies has made an impressive move with the opening of a 60-bed Behavioral Health Unit at Shawnee County Jail in Topeka, Kansas. The unit, part of a $21 million expansion completed on August 24, is set to change the landscape for inmates needing mental health and substance use treatment. This isn't just a slap...

Continue Reading
Illinois' Legal Tangle: Feds Under Fire?

Updated Category News Views 2

What a tangled web Illinois lawmakers have woven this time. They've gone and cooked up a pair of laws with a real knack for attracting attention—specifically from the folks over at the National Police Association (NPA). These aren’t your run-of-the-mill rules; they feel more like a blueprint for putting federal officers through the legal wringer and turning courtroom...

Continue Reading
Drunk Angel Celebrates First Year in Crystal Jewelry

Updated Category News Views 2

One Year Down, A Unique Path Forward It's been a year since Drunk Angel jumped into the online jewelry scene, and they're setting themselves apart in their own glittery lane. Imagine starting a brand that's not just about pretty trinkets, but about linking those tiny treasures to timeless traditions. They've got their sights set on blending the deep tales of gemstones...

Continue Reading
IDX Expands, Enhances Team Amid 56% H1 Growth

Updated Category News Views 1

IDX's Aggressive Global Expansion Here's a tip from a trader who’s seen cycles rise and fall: watch the movers who're playing the long game, putting down roots worldwide while making headway in the data game. IDX has clearly mapped out this trajectory as evidenced by its recent grab in the global strategic communications ring. IDX's bustling around like a squirrel...

Continue Reading

Top 5 Most Recently Viewed Articles

Nextchip and Arteris Collaborate for Advanced Automotive Vision

Updated Category News Views 156

Nextchip Teams Up with Arteris for Enhanced Automotive Vision Nextchip, a forerunner in automotive semiconductor designs, has recently engaged Arteris, Inc., known for its expertise in system IP, to bolster its development of advanced vision technology in vehicles. Utilizing Arteris' renowned FlexNoC network-on-chip (NoC) interconnect IP equipped with Functional Safety...

Continue Reading
Conduent's Strategic Growth in Q3 2025 Revealed

Updated Category News Views 193

Key Q3 2025 Highlights Conduent Incorporated (NASDAQ: CNDT), a leading global technology-driven business process solutions provider, recently shared its financial results for the third quarter of 2025. This quarter saw the successful completion of significant milestones that forecast not only growth but also innovative operational strategies. Financial Overview Total...

Continue Reading
Pennant Group's Strong Fiscal Year 2024 Performance Review

Updated Category News Views 194

Pennant Group's Financial Highlights for Fiscal Year 2024 In a compelling display of resilience and growth, The Pennant Group, Inc. (NASDAQ: PNTG) has unveiled its financial performance for the fiscal year 2024, showcasing remarkable achievements across various operational segments. The company reported GAAP diluted earnings per share of $0.70 for the entire fiscal year...

Continue Reading
NTG Nordic Transport Group's H1 2025 Interim Results Summary

Updated Category News Views 219

NTG Nordic Transport Group's Interim Report for H1 2025 NTG Nordic Transport Group has successfully released its interim report for the first half of 2025. This report provides essential insights into the company's performance during this period and outlines future strategies. Financial Performance Overview In this interim report, NTG presents a comprehensive analysis of...

Continue Reading
Cytokinetics Highlights Employee Stock Options and RSU Grants

Updated Category News Views 228

Employee Stock Options and RSU Grants by Cytokinetics Cytokinetics, Incorporated (Nasdaq: CYTK) recently made headlines by granting stock options and restricted stock units (RSUs) to new employees. This strategic move took place in mid-October 2025, marking a significant step in the company’s effort to attract and retain talent within the biopharmaceutical industry....

Continue Reading